Canada Medical Marijuana News

Another Canadian medical cannabis producer goes public

John Schroyer  | March 22, 2017

Adding to a growing trend among licensed Canadian medical marijuana producers, Hydropothecary Corp. went public Tuesday.

The Quebec-based company started trading on the TSX Venture Exchange after completing a reverse takeover with BFK Capital Corp. last week, the Financial Post reported.

Hydropothecary shares opened at 1.82 Canadian dollars ($1.36) and closed at CA$1.55 …

Canadian marijuana cultivators are raking in capital

Omar Sacirbey  | March 17, 2017

Canada’s federally licensed medical marijuana cultivation companies have raised roughly 700 million Canadian dollars ($524 million) in the past six months, according to canna-centric analysis firm Canaccord Genuity.

The investment frenzy started in the third quarter of 2016 when investors injected more than CA$150 million ($112 million) into publicly traded and privately held Canadian …

Third lawsuit launched in Canada over tainted medical marijuana

Bart Schaneman  | March 16, 2017

A third proposed class-action lawsuit over pesticide-laden medical marijuana in Canada raises additional questions about Health Canada’s claim that people who consumed the tainted cannabis weren’t becoming ill.

According to The Globe and Mail, the Nova Scotia man listed in the new proposed class action allegedly became violently ill after consuming medical marijuana he …

Marijuana CEO calls for strict product testing in Canada

Omar Sacirbey  | March 14, 2017

The CEO of one of Canada’s biggest medical marijuana cultivators wants to see the country’s public health department implement a strict system of product testing for cannabis companies after recent pesticide-related recalls.

Marijuana companies should foot the bill for the increased inspections and tests, said Vic Neufeld, CEO of Aphria Inc., adding that …

Week in Review: Los Angeles marijuana vote, Canada rec rollout & new cannabis standards

John Schroyer  | March 10, 2017

By John Schroyer, Omar Sacirbey and Bart Schaneman

Los Angeles voters approve a groundbreaking marijuana initiative, Canada adult-use legalization may take longer than anticipated, and an influential standards-setting group eyes cannabis.

Here’s a closer look at some notable developments in the marijuana industry over the past week.

Second Canadian medical cannabis firm target of class-action suit

Bart Schaneman  | March 8, 2017

A second Canadian medical cannabis producer embroiled in a controversy over tainted marijuana is the target of a proposed class-action lawsuit by patients who unwittingly consumed prohibited pesticides.

According to the Globe and Mail, Mettrum, in addition to OrganiGram, was found selling MMJ containing pesticide myclobutanil, which emits hydrogen cyanide that, when lit, and can cause …

Canadian medical cannabis firm targeted in class-action suit

John Schroyer  | March 7, 2017

Canadian medical marijuana producer Organigram, having already replaced its CEO, now is the subject of a proposed class-action lawsuit involving pesticide-contaminated cannabis.

A court must  certify the proposed lawsuit before it can proceed.

A Halifax-based law firm alleged in its Friday filing that the lead plaintiff consumed Organigram’s MMJ products for almost a year …

Week in Review: Canada’s tainted MMJ, tribal grow operation & DOJ policies

Bart Schaneman  | March 3, 2017

By Omar Sacirbey, Bart Schaneman and John Schroyer

The fallout continues over pesticide-contaminated medical marijuana in Canada, a giant MJ greenhouse is planned for tribal land, and Jeff Sessions’ Justice Department will enact “reasonable policies” on cannabis.

Here’s a closer look at some notable developments in the marijuana industry over the past week.